Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 21,603 shares at $9.25 ($200K) on 2023-08-15, disclosed to the SEC on 2023-08-17.
Scheduled sale ($200k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.19 | 3,603 | $33K | 16.6% |
| 2 | $9.25 | 18,000 | $167K | 83.4% |
| Total | $9.24 avg | 21,603 | $200K | 100% |
| Filing → |
| RXRX | SELL | 2023-11-17 | $117K | — | Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |